Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Merus N.V. NasdaqGM:MRUS |
6,83 B | -13,40% | 1/6 | -95,00% | -853,13% | -100,00% | UP |
|
NewAmsterdam Pharma Company N.V. NasdaqGM:NAMS |
3,55 B | 0,00% | 0/0 | 23,52% | -179,86% | 64,88% | UP |
|
Pharvaris N.V. NasdaqGS:PHVS |
2,20 B | 0,00% | 1/4 | 0,00% | 0,00% | 31,77% | UP |
|
uniQure N.V. NasdaqGS:QURE |
1,67 B | -21,40% | 2/6 | 48,51% | -585,93% | 32,28% | UP |
|
Pharming Group N.V. ENXTAM:PHARM |
0,77 B | 6,28% | 1/5 | 23,25% | -42,24% | 100,91% | DOWN |
|
Kiadis Pharma N.V. ENXTAM:KDS |
0,33 B | 0,00% | 0/3 | 0,00% | 0,00% | -100,00% | DOWN |
|
ProQR Therapeutics N.V. NasdaqCM:PRQR |
0,16 B | 36,88% | 4/5 | -11,26% | 70,53% | 478,23% | DOWN |
|
LAVA Therapeutics N.V. NasdaqGS:LVTX |
0,05 B | 29,62% | 0/0 | -100,00% | -1233,68% | -100,00% | UP |
|
Esperite N.V. ENXTAM:ESP |
0,00 B | 0,00% | 0/2 | 0,00% | 0,00% | -100,00% | DOWN |
